$ABPO News

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.

Which stocks are moving on Thursday?

Which stocks are experiencing notable movement on Thursday?

Is Abpro Holdings Inc Gaining or Losing Market Support?

Let's uncover which stocks are experiencing notable gaps during today's session.

These stocks are making the most noise in today's session.

In today's session, these stocks are experiencing unusual volume.

Gold Moves Lower; CVS Health Earnings Top Views

12 Health Care Stocks Moving In Tuesday's Intraday Session

Dow Surges Over 200 Points; Coca-Cola Posts Mixed Q4 Results

Abpro Holdings shares are trading higher after a 13G filing disclosed that Goldman Sachs Group has a 6.8% stake in the company.

Abpro Holdings FormSCHEDULE 13G Shows THE GOLDMAN SACHS GROUP Has 6.8% Stake In Co.

12 Health Care Stocks Moving In Wednesday's Intraday Session

Abpro’s Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference

Abpro Holdings shares are trading higher after the company announced that the FDA has cleared the Investigational New Drug application for its lead multispecific antibody oncology program ABP-102 / CT-P72.

Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72

Abpro and Celltrion to Start Global Trial of Targeted HER2+ Cancer Antibody in Early 2026

Abpro Holdings Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T cell engager ABP-102/CT-P72 for HER2-positive Cancers

Abpro And Its Co-development Partner Celltrion Submitted An Investigational New Drug Application To FDA For ABP-102/CT-P72 HER2-Positive Cancers

12 Health Care Stocks Moving In Monday's Pre-Market Session